FDA Warning Letter — Microvascular Tissue, Inc
The FDA took a Warning Letter action against Microvascular Tissue, Inc on December 3, 2025 (San Diego, CA). The action was issued by CBER and concerns biologics products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Microvascular Tissue, Inc
- Date
- December 3, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Center
- CBER
- Location
- San Diego, CA (United States)